KYMR Company Profile and Key Details

Q: Who are the executives of KYMR?

Ms. Karen WeisbachVice President of People & CultureMs. Elaine CaugheyChief Bus. OfficerDr. Jared A. Gollob M.D.Chief Medical OfficerDr. Bruce L. Booth D.Phil., DPHIL, Ph.D.Co-Founder & ChairmanMr. Bruce N. Jacobs CFAChief Financial OfficerKevin DushneySenior Vice President of IT & OperationsMs. Melissa BrodyVice President of Bus. Devel.Mr. Michael J. TodiscoVice President of Accounting & Fin.Dr. Nello Mainolfi M.D., Ph.D.Co-Founder, Pres, Chief Executive Officer & DirectorMs. Ellen V. Chiniara Esq., J.D.Chief Legal Officer & Corporation Sec.Dr. Jeremy G. Chadwick Ph.D.Chief Operating OfficerMr. Vijay SabesanSenior Vice President of Technical Operations

NASDAQ : KYMR

Kymera Therapeutics

$115.43

-1.04-0.89%

At Close 4:00 PM

59.02

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Kymera Therapeutics, Inc. (KYMR) stock declined over -0.89%, trading at $115.43 on NASDAQ, down from the previous close of $116.47. The stock opened at $115.34, fluctuating between $114.50 and $120.67 in the recent session.

Stock Snapshot

116.47

Prev. Close

9.49B

Market Cap

114.5

Day Low

-36.07

P/E Ratio

-3.2

EPS (TTM)

-2.35

Cash Flow per Share

115.34

Open

82.26M

Number of Shares

120.665

Day High

82.62%

Free Float in %

6.75

Book Value

767.42K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 09, 2026	115.34	120.67	113.18	115.43	765.34K
Sep 08, 2026	114.41	120.22	113.97	116.47	631.28K
Sep 04, 2026	115.09	118.28	112.77	117.39	378.57K
Sep 03, 2026	118.63	119.26	115.55	117.28	591.58K
Sep 02, 2026	119.58	123.54	117.42	118.63	982.95K
Sep 01, 2026	116.92	119.79	116.28	119.05	576.56K
Aug 31, 2026	118.60	119.93	115.97	118.81	656.83K
Aug 28, 2026	119.40	121.98	117.48	118.15	415.93K
Aug 27, 2026	124.99	125.07	119.98	120.23	594.82K
Aug 26, 2026	126.24	126.32	123.39	125.55	552.91K
Aug 25, 2026	122.64	127.85	121.60	126.64	925.75K
Aug 24, 2026	119.98	121.56	116.46	121.05	466.85K
Aug 21, 2026	122.87	125.71	119.77	119.80	503.43K
Aug 20, 2026	124.95	125.45	121.13	121.50	573.85K
Aug 19, 2026	124.63	127.36	121.83	127.31	842.75K
Aug 18, 2026	119.75	122.14	118.09	121.38	632.35K
Aug 17, 2026	117.39	122.59	117.04	121.41	704.49K
Aug 14, 2026	112.90	118.04	110.05	117.39	468.54K
Aug 13, 2026	114.73	114.73	112.44	114.42	481.71K
Aug 12, 2026	110.22	115.00	109.09	114.03	959.97K

Contact Details

Watertown, MA 02472

United States

https://www.kymeratx.com 857 285 5300

About Company

Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.

Stock Peers

ARGX

-4.76-0.47%

argenx SE$1,002.31 REGN

-2.66-0.33%

Regeneron Pharmaceuticals, Inc.$807.65 MDGL

12.5+2.34%

Madrigal Pharmaceuticals, Inc.$546.66 VRTX

-7.78-1.47%

Vertex Pharmaceuticals Incorporated$521.12 UTHR

8.85+1.78%

United Therapeutics Corporation$506.82 ONC

-0.48-0.14%

BeOne Medicines AG$351.00 KRYS

-3.17-0.90%

Krystal Biotech, Inc.$348.09 PRAX

-7.18-2.04%

Praxis Precision Medicines, Inc.$345.30 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

-0.78-0.27%

Ligand Pharmaceuticals Incorporated$288.05

Frequently Asked Questions

What is the current Kymera Therapeutics, Inc. (KYMR) stock price?

Kymera Therapeutics, Inc. (NASDAQ: KYMR) stock price is $115.43 in the last trading session. During the trading session, KYMR stock reached the peak price of $120.67 while $114.50 was the lowest point it dropped to. The percentage change in KYMR stock occurred in the recent session was -0.89% while the dollar amount for the price change in KYMR stock was - $1.04.

KYMR's industry and sector of operation?

The NASDAQ listed KYMR is part of Biotechnology industry that operates in the broader Healthcare sector. Kymera Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of KYMR?

Ms. Karen Weisbach
Vice President of People & Culture
Ms. Elaine Caughey
Chief Bus. Officer
Dr. Jared A. Gollob M.D.
Chief Medical Officer
Dr. Bruce L. Booth D.Phil., DPHIL, Ph.D.
Co-Founder & Chairman
Mr. Bruce N. Jacobs CFA
Chief Financial Officer
Kevin Dushney
Senior Vice President of IT & Operations
Ms. Melissa Brody
Vice President of Bus. Devel.
Mr. Michael J. Todisco
Vice President of Accounting & Fin.
Dr. Nello Mainolfi M.D., Ph.D.
Co-Founder, Pres, Chief Executive Officer & Director
Ms. Ellen V. Chiniara Esq., J.D.
Chief Legal Officer & Corporation Sec.
Dr. Jeremy G. Chadwick Ph.D.
Chief Operating Officer
Mr. Vijay Sabesan
Senior Vice President of Technical Operations

How KYMR did perform over past 52-week?

KYMR's closing price is 170.3% higher than its 52-week low of $42.71 where as its distance from 52-week high of $130.05 is -11.24%.

How many employees does KYMR have?

Number of KYMR employees currently stands at 273.

Link for KYMR official website?

Official Website of KYMR is: https://www.kymeratx.com

How do I contact KYMR?

KYMR could be contacted at phone 857 285 5300 and can also be accessed through its website. KYMR operates from 500 North Beacon Street, Watertown, MA 02472, United States.

How many shares of KYMR are traded daily?

KYMR stock volume for the day was 767.42K shares. The average number of KYMR shares traded daily for last 3 months was 855.02K.

What is the market cap of KYMR currently?

The market value of KYMR currently stands at $9.49B with its latest stock price at $115.43 and 82.26M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	273
Beta	1.95
Sales or Revenue	$78.59M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	273
Beta	1.95
Sales or Revenue	$78.59M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

KYMR Company Profile and Key Details

Kymera Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Earnings & Analyst Outlook

Company Overview

Valuation Metrics

Dividend & Fair Value

Price Forecast & Outlook

Key Takeaways